Research Locations
The Tzagournis Medical Research Facility was officially named in 1999 after Dr. Manuel Tzagournis. This eight-story facility houses generic research laboratories and support facilities.
Manuel Tzagournis received his BS in 1956 and his MD in 1960 from OSU. Tzagournis has held numerous positions at OSU including Assistant Dean for Research and Continuing Medical Education; Secretary of the Faculty of the College of Medicine; Associate Dean; Medical Director for OSU Hospitals; Acting Dean (1980); Dean (1981-1995); Vice President for Health Sciences (1994-2002); and Vice President and President of the University’s Managed Care System.
The Ohio Lions Eye Research Foundation (OLERF) donated $500,000 to build the OLERF Laboratory in the Tzagournis Medical Research Facility. Colleen Cebulla, MD, PhD currently occupies the lab for her research and has been awarded several large grants.
Wiseman Hall was built in 1960 and serves as the major animal research facility of the College of Medicine. It was named for Bruce K. Wiseman in 1963.
Dr. Wiseman came to OSU in 1931. He was an associate professor of medicine and associate director of medical research (1931-1935); Associate professor of medicine (1935-1938); Professor of Medicine (1938-1960); Chair of the Department of Medicine (1944-1960); chief of staff of OSU Hospitals (1948-1960). Along with his colleague Dr. Charles Doan, Wiseman made significant contributions to the field of hematology.
The Retina Division has a long tradition of clinical research. Frederick Davidorf, MD published much of his early work on the natural history and management of choroidal melanomas and other ocular tumors. Money from grateful patients Warner and Patti Blow allowed him to establish a laboratory at Wiseman Hall for the investigation of retinal angiogenesis and melanoma genetics. Several residents, research fellows and Mohamed Abdel-Rahman, MD, PhD were members of Dr. Davidorf’s research team.
The Pelotonia Research Center is the first new building to open at Carmenton, Ohio State's innovation district. This five-story, 305,000-square-foot laboratory building is equipped with new spaces, technologies, and resources needed for researchers to work across disciplines to accelerate discoveries. Innovation at the Pelotonia Research Center will focus on areas including cancer, gene- and cell-based therapies, cardiovascular and pulmonary medicine, neurological disease, microbiome, food systems and health, artificial intelligence, sensory biology, and social and environmental determinants of health.
Chair - Sayoko Moroi, MD, PhD will work with our vision scientists in the PRC: Shigeo Tamiya, PhD goal is to develop new treatments to prevent or limit excessive scarring, and potentially improve surgical and vision outcomes. Nagaraj Kerur, DVM, PhD focus is to identify new potential therapeutic targets for Age-Related Macular Degeneration (AMD) to prevent blindness. Thomas Mendel, MD, PhD is building a genetics program to develop and implement gene therapies in patients with Inherited Retinal Diseases.